Skip to search formSkip to main contentSkip to account menu

23-valent pneumococcal capsular polysaccharide vaccine

Known as: 23-valent vaccine, pneumococcal polysaccharide PPV23, PCV 23 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract Older adults, particularly those with chronic obstructive pulmonary disease, are advised to receive 23-valent… 
2016
2016
ABSTRACT Introduction: Diseases caused by Streptococcus pneumoniae are a major public health problem worldwide, which can be… 
2014
2014
The current study examined the safety and immunogenicity of 23-valent pneumococcal capsular polysaccharide vaccine (Pneumo23… 
Review
2012
Review
2012
Purpose of review Pneumococcal glycoconjugate vaccines (PCVs) are now widely used in infant immunization schedules. These… 
Review
2012
Review
2012
For the influenza pandemic of 2009-2010, countries responded to the direct threat of influenza but may have missed opportunities… 
Highly Cited
2010
Highly Cited
2010
This study evaluated safety & immunogenicity of ZOSTAVAX® (zoster vaccine: ZV) administered concomitantly versus nonconcomitantly…